E- and P-Selectins Are Essential for Repopulation of Chronic Myelogenous and Chronic Eosinophilic Leukemias in a Scid Mouse Xenograft Model

Overview of attention for article published in PLOS ONE, July 2013

Altmetric Badge

Mentioned by

patent: 10 patents

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 26 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 10 patents that reference this research output.

Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists

Grant US-11878026-B2

United States of America

Heterobifunctional inhibitors of E-selectin and galectin-3

Grant US-11845771-B2

United States of America

Highly potent multimeric e-selectin antagonists

Grant US-11780873-B2

United States of America

Methods of mobilizing marrow infiltrating lymphocytes and uses thereof

Grant US-11712446-B2

United States of America

Methods for treating acute myeloid leukemia and related conditions

Grant US-11707474-B2

United States of America

Heterobifunctional inhibitors of E-selectin and galectin-3

Grant US-11548908-B2

United States of America

Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or…

Grant US-11433086-B2

United States of America

Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-se…

Grant US-11291678-B2

United States of America

Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists

Grant US-11197877-B2

United States of America

Highly potent multimeric e-selectin antagonists

Grant US-11072625-B2

United States of America